RECRUITING

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

Official Title

RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Quick Facts

Study Start:2020-03-19

Study Completion:2026-05-27

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT04342429

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Pathologically confirmed small cell lung cancer, limited or extensive stage. * Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist. * Age 18 or greater	* Prior radiation therapy which would provide significant dose overlap with the planned target volume(s) * Pregnancy

Contacts and Locations

Study Contact

Kristin Higgins, MD

CONTACT

404-778-0603

kristin.higgins@emory.edu

Allyson Anderson

CONTACT

404-251-2854

allyson.anderson@emory.edu

Principal Investigator

Kristin Higgins, MD

PRINCIPAL_INVESTIGATOR

Emory University-Winship Cancer Institute

Study Locations (Sites)

Winship Cancer Institute

Atlanta, Georgia, 30322

United States

Collaborators and Investigators

Sponsor: Emory University

Kristin Higgins, MD, PRINCIPAL_INVESTIGATOR, Emory University-Winship Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-03-19

Study Completion Date2026-05-27

Study Record Updates

Study Start Date2020-03-19

Study Completion Date2026-05-27

Terms related to this study

Additional Relevant MeSH Terms

Small-cell Lung Cancer